Changing Spectrum of Hair and Scalp Disorders Over the Last Decade in a Tertiary Medical Centre

    Anna Lyakhovitsky, Ido Tzanani, Shlomo Gilboa, Omer Segal, Eran Galili, Sharon Baum, Aviv Barzilai
    Image of study
    TLDR Hair and scalp disorder visits at a medical center increased over the past decade.
    The study "Changing spectrum of hair and scalp disorders over the last decade in a tertiary medical centre" analyzed medical records from the Sheba Medical Center in Israel, covering 10,396 hair and scalp-related disorder (HSRD) visits from 2010 to 2020. The study found that the annual number of HSRD visits, and their proportion of all dermatological outpatient visits, increased from 295 (1.24%) in 2010 to 1726 (9.44%) in 2020. The average patient age was 35.3 years, with a growing predominance of women (2:1 female-to-male ratio). The most common HSRDs were androgenetic alopecia (30.6%), alopecia areata (19.3%), and telogen effluvium (15.4%). The study concluded that HSRDs account for a significant percentage of visits at a tertiary dermatology outpatient clinic, and the number of HSRD visits has increased annually over the past decade, possibly due to advancements in diagnosis and treatment.
    Discuss this study in the Community →

    Research cited in this study

    20 / 20 results

    Related Community Posts Join

    6 / 1000+ results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  40 upvotes 1 year ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.

      community AGA evaluation and first steps - BEGINNER MEGAPOST

      in Chat  73 upvotes 2 months ago
      The conversation discusses androgenic alopecia (AGA) and its treatments, focusing on finasteride, minoxidil, and ketoconazole shampoo. Finasteride is recommended as essential for preventing further hair loss.

    Related Research

    1 / 1 results